Environmental epidemiology of Kawasaki disease: Linking disease etiology, pathogenesis and global distribution | PLOS ONE
Cumulative recurrence rates of Kawasaki disease calculated by different... | Download Scientific Diagram
Rheumato | Free Full-Text | Kawasaki Disease: Management Challenges during COVID-19 Pandemic with an Upsurge in Multisystem Inflammatory Syndrome in Children
Late Treatment and Recurrence of Kawasaki Disease in a Moroccan Infant
Combination therapy reduces risk for abnormalities, treatment failure in Kawasaki disease
Frontiers | Increased Incidence of Kawasaki Disease in Taiwan in Recent Years: A 15 Years Nationwide Population-Based Cohort Study
Frontiers | Epidemiology of Kawasaki Disease in Europe
Long-term Consequences of Kawasaki Disease | Circulation
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation
Is it Kawasaki Disease or Multisystem Inflammatory Syndrome in Children? - ScienceDirect
Clinical Practice Guidelines : Kawasaki disease
Kawasaki disease: insights into pathogenesis and approaches to treatment | Nature Reviews Rheumatology
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease | Circulation
Clinical characteristics of patients with recurrent Kawasaki disease: a nationwide cohort study of 19 456 patients with minimum 3-year follow up | Archives of Disease in Childhood
Comparative Effectiveness of Intravenous Immunoglobulin for Children with Kawasaki Disease: A Nationwide Cohort Study | PLOS ONE
Epidemiologic features of Kawasaki disease in acute stages in Taiwan, 1997–2010: Effect of different case definitions in claims data analysis - ScienceDirect
Frontiers | How Should We Classify Kawasaki Disease?
Clarithromycin Plus Intravenous Immunoglobulin Therapy Can Reduce the Relapse Rate of Kawasaki Disease: A Phase 2, Open‐Label, Randomized Control Study | Journal of the American Heart Association
Abstract 134: Early Immunoglogulin Therapy and Outcomes of Kawasaki Disease | Circulation
Kawasaki disease: pathophysiology and insights from mouse models | Nature Reviews Rheumatology
Kawasaki disease: guidelines of Italian Society of Pediatrics, part II - treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks | Italian Journal of Pediatrics | Full Text
Children | Free Full-Text | Major Complication Following Kawasaki Disease in an Infant—The Development of Apical Infarction and Aneurysm Formation
Kawasaki Disease: Practice Essentials, Background, Pathophysiology
Kawasaki Disease
Clinical characteristics of patients with recurrent Kawasaki disease: a nationwide cohort study of 19 456 patients with minimum 3-year follow up | Archives of Disease in Childhood
Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text
Defining the risk of first intravenous immunoglobulin unresponsiveness in non-Asian patients with Kawasaki disease | Scientific Reports
